Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...
Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.
Examination of Decipher prostate genomic classifier in patients with de novo metastatic disease from a large scale real-world clinical and transcriptomic data linkage. This is an ASCO Meeting Abstract ...
In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results